Chemistry at AVIGI and Strengthening our Team Leiden, The Netherlands - AVIGI Therapeutics, a biotech company dedicated to transforming how diabetic kidney disease is treated strengthens chemistry alliance with Leiden University. We have been awa...
The hidden link in heart and kidney disease? Hey everyone, we’re back with another published literature dive into the future of kidney health. But this time, we’re stepping back from the kidney itself and looking at the bigger picture. Because w...
AVIGI welcomes Prof. Hiddo J. L. Heerspink to advisory team LEIDEN, Netherlands — AVIGI Therapeutics B.V., a pre-clinical stage biopharmaceutical company specializing in covalent small-molecule drugs, is keen to announce the addition of Professor Hiddo Lambers...
Animal, Artificial, or Lab-Grown? Hey everyone, we’re back with our AVIGI special on impactful innovations in kidney health. And for this edition, we’re diving into something that many might initially mistake for pure science fiction ...
Your Window to Kidney Health? Hey everyone, I'm Dilara, AVIGI's Science and Business Associate! At AVIGI Therapeutics, we're always on the lookout for the next impactful innovation in health science that furthers our mission. Toda...
Esteemed Professor in Nephrology Joins AVIGI Therapeutics' advisory team AVIGI Therapeutics is honored to welcome Prof. Dr. Johan van der Vlag , a distinguished Professor of Experimental Nephrology, Immunology of Kidney Diseases and Transplantation at Radboud University Me... Leadership
AVIGI Shifts Gears for Maximum Impact LEIDEN, Netherlands – September 19, 2025 – AVIGI today announces a strategic decision to prioritise the development of its lead asset, VL166, in the field of kidney disease, while evolving its oncolog...
AVIGI adds Prof. Dr. Adam Cohen to advisory team LEIDEN, June 4, 2025 — AVIGI Therapeutics is thrilled to add Prof. Dr. Adam Cohen to it's scientific advisory team. Adam graduated as a pharmacist and a physician from Leiden University and was traine... Leadership
AVIGI Assembles World-Class Scientific Advisors to Catapult it's First-in-Class Therapeutic. LEIDEN, May 7, 2025 — AVIGI Therapeutics is proud to announce the formation of its Scientific Advisory team, bringing together internationally recognized leaders in glycobiology and drug development. ... Leadership
AVIGI is attending BIO 2025 - Meet us in Boston! When? June 16-19, 2025 Where? BIO 2025: Boston Convention Exhibition Center 🇺🇸 - USA Why? As we advance our innovative therapeutic programs in oncology and inflammatory diseases, we're eager to engage... Global Tour
AVIGI is going East - Meet us in Shanghai! When? May 12-18, 2025 Where? European Hi-Tech Delegation China Tour: Shanghai Ningbo 🇨🇳 - China Why? As we expand our outreach beyond Europe, we're eager to engage with key industry players, potential... Global Tour
AVIGI Therapeutics Welcomes Dr. Alessandro Noseda as Medical Advisor AVIGI Therapeutics, a pioneering biotechnology company leveraging biomimetic rational drug design and advanced chemistry, is pleased to announce the appointment of Dr. Alessandro Noseda as its Medical... Leadership